Quality of informed consent in cancer clinical trials: a cross-sectional survey

  title={Quality of informed consent in cancer clinical trials: a cross-sectional survey},
  author={Steven Joffe and E. Francis Cook and Paul D. Cleary and Jeffrey W. Clark and Jane C. Weeks},
  journal={The Lancet},

Tables from this paper

Quality of informed consent in cancer clinical trials in India: A cross-sectional survey
Thorough patient counselling is crucial to minimize ‘therapeutic misconception’ to preserve the validity of informed consent in cancer trials, and important deficiencies in research participants’ understanding of essential elements ofinformed consent are revealed.
Quality of informed consent: measuring understanding among participants in oncology clinical trials.
The Quality of Informed Consent questionnaire may be a useful tool for monitoring the quality of the informed consent process and contributing to patients' understanding of clinical trials and the research process.
Consent in clinical trials: what do patients know?
Consent for participating in clinical trials - Is it really informed?
The article explores the challenges of ensuring voluntary and informed consent which is obtained from potential research subjects in the north-eastern part of Romania and finds that the most important predictive factor for a good subjective and objective understanding of the clinical trial was the level of education.
Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception
The authors suggest that the risk of therapeutic misconception be specifically addressed in consent forms as an educational tool for both patients and investigators.
Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey
A high proportion of patients were willing to donate tissue for research and to consider trials involving repeat biopsies, and the majority of patients feel that participants should be informed of trial results and there is a group of patients who would like more detailed trial information.
The quality of informed consent in a clinical research study in Thailand.
Very little is known about the quality of informed consent given by Thai subjects in HIV studies, but because there has been a considerable volume of clinical research in Thailand including HIV research, Thai citizens may be more familiar with and experienced in research overall than people in other resource poor countries.
Cancer clinical trial participants' assessment of risk and benefit
Findings have important implications for understanding the role of assessing risks and benefits in the research participation decisions of patients with cancer and call for further understanding of why participants are not assessing information believed to be essential for autonomous informed decisions.
Evaluation of the Informed Consent Process of a Multicenter Tuberculosis Treatment Trial
Through this pilot evaluation, complexities and challenges were identified in obtaining consent in a large, international multicenter trial and provided insights for a more robust assessment of the consent process in future trials.


Quality of informed consent: a new measure of understanding among research subjects.
The Quality of Informed Consent questionnaire, the QuIC, is a brief, reliable, and valid questionnaire that holds promise as a standardized way to assess the outcome of the informed consent process in cancer clinical trials.
Perceptions of cancer patients and their physicians involved in phase I trials.
Cancer patients who participate in phase I trials appear to have an adequate self-perceived knowledge of the risks of investigational agents, however, only a minority of patients appear toHave an adequate understanding of the purpose of phase I Trials as dose-escalation/dose-determination studies.
Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer.
A randomised study was performed to compare two commonly adopted methods of seeking consent to randomised treatment: an individual approach at the discretion of each doctor and a uniform policy of total disclosure of all relevant information.
Informed consent for investigational chemotherapy: patients' and physicians' perceptions.
  • D. Penman, J. Holland, R. Cherry
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1984
Patients and physicians studied for their perceptions of the consent procedure for chemotherapy by one of 65 investigational protocols believed therapeutic benefits would exceed potential problems for most patients and viewed patients as less than eager for details of treatment, a third as avoiding the seriousness of the discussion, and a second as passive in decision-making.
Monitoring informed consent in an oncology study posing serious risk to subjects.
The consent monitoring process devised by the IRB and the results obtained are described, including growth factors, peripheral stem cell transfusion, parenteral nutrition, antibiotics, and, if necessary, admission to the intensive care unit.
Informed consent to biomedical research in Veterans Administration Hospitals.
Patients knew they were research subjects, had voluntarily consented, and knew the details of their medical treatment, but few understood the research well; readability analysis indicated that consent forms required college-level education.
A simple technique for increasing cancer patients' knowledge of informed consent to treatment
Patients referred to a radiation oncology clinic for treatment of malignant neoplasms were tested for their immediate recall of information presented, recorded, and signed on informed consent documents, indicating a tendency for younger patients to recall more informed consent information than older patients.
The Deaconess Informed Consent Comprehension Test: An Assessment Tool for Clinical Research Subjects
The Deaconess Informed Consent Comprehension Test is a reliable instrument to assess comprehension of informed consent information and there is preliminary evidence for the scale's validity.